𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A pilot double-blind randomized placebo-controlled study of molsidomine 16

✍ Scribed by Roger Messin; Tamas Fenyvesi; Fabienne Carreer-Bruhwyler; Jacques Crommen; Patrice Chiap; Philippe Hubert; Claude Dubois; Jean-Pierre Famaey; Joseph Géczy


Publisher
Springer
Year
2003
Tongue
English
Weight
219 KB
Volume
59
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Rifaximin for the treatment of active po
✍ Kim L. Isaacs; Robert S. Sandler; Maria Abreu; Michael F. Picco; Stephen B. Hana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with

Randomized, placebo-controlled, double-b
✍ Andrea Martinuzzi; Alexandra Liava; Enrico Trevisi; Mara Frare; Caterina Tonon; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

## Abstract McArdle's disease causes limitation in exercise capacity as well as disability, the severity of which has been associated with the angiotensin‐converting enzyme (ACE) insertion (I)/deletion (D) haplotype—patients with the genotype associated with higher ACE activity show the most severe

Mirtazapine in essential tremor: A doubl
✍ Rajesh Pahwa; Kelly E. Lyons 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 1 views

## Abstract We sought to determine whether mirtazapine is safe and well‐tolerated as a treatment for essential tremor (ET). We studied mirtazapine in a randomized, double‐blind, placebo‐controlled, crossover study of 17 ET patients. Patients were started with 15 mg per day of either mirtazapine or